#NEWS: #Lantheus today announced the worldwide exclusive rights to a Ph. 3 ß amyloid PET imaging agent through the acquisition of Meilleur Technologies, Inc., expanding the Company’s pipeline & ability to #FindFightFollow #AlzheimersDisease. ➡️ https://t.co/AQj4aN7pmy https://t.co/2EiWUtUxIh
July 15, 2024
View Tweet